Vaccination proposal for patients on onasemnogene abeparvovec therapy
Eur J Paediatr Neurol. 2024 Mar 1;49:95-99. doi: 10.1016/j.ejpn.2024.02.010. Online ahead of print.ABSTRACTThe approval of disease-modifying treatment in spinal muscular atrophy made the condition less severe. The course of the disease changed, but some new concerns occurred with the different new therapies. The side effects of onasemnogene aboparvovec therapy can raise differential diagnostic challenges and necessitate immune therapy, leading to immunosuppression affecting response to vaccines. We provide a pretherapy screening proposal from an infectological point of view separately for newborns treated presymptomaticall...
Source: European Journal of Paediatric Neurology - March 8, 2024 Category: Neurology Authors: Sarolta Dobner Andrea Kulcs ár Zolt án Liptai Zsuzsanna Vojnisek Tam ás Constantin L éna Szabó Source Type: research

Vaccination proposal for patients on onasemnogene abeparvovec therapy
Eur J Paediatr Neurol. 2024 Mar 1;49:95-99. doi: 10.1016/j.ejpn.2024.02.010. Online ahead of print.ABSTRACTThe approval of disease-modifying treatment in spinal muscular atrophy made the condition less severe. The course of the disease changed, but some new concerns occurred with the different new therapies. The side effects of onasemnogene aboparvovec therapy can raise differential diagnostic challenges and necessitate immune therapy, leading to immunosuppression affecting response to vaccines. We provide a pretherapy screening proposal from an infectological point of view separately for newborns treated presymptomaticall...
Source: European Journal of Paediatric Neurology - March 8, 2024 Category: Neurology Authors: Sarolta Dobner Andrea Kulcs ár Zolt án Liptai Zsuzsanna Vojnisek Tam ás Constantin L éna Szabó Source Type: research

Vaccination proposal for patients on onasemnogene abeparvovec therapy
Eur J Paediatr Neurol. 2024 Mar 1;49:95-99. doi: 10.1016/j.ejpn.2024.02.010. Online ahead of print.ABSTRACTThe approval of disease-modifying treatment in spinal muscular atrophy made the condition less severe. The course of the disease changed, but some new concerns occurred with the different new therapies. The side effects of onasemnogene aboparvovec therapy can raise differential diagnostic challenges and necessitate immune therapy, leading to immunosuppression affecting response to vaccines. We provide a pretherapy screening proposal from an infectological point of view separately for newborns treated presymptomaticall...
Source: European Journal of Paediatric Neurology - March 8, 2024 Category: Neurology Authors: Sarolta Dobner Andrea Kulcs ár Zolt án Liptai Zsuzsanna Vojnisek Tam ás Constantin L éna Szabó Source Type: research

Vaccination proposal for patients on onasemnogene abeparvovec therapy
Eur J Paediatr Neurol. 2024 Mar 1;49:95-99. doi: 10.1016/j.ejpn.2024.02.010. Online ahead of print.ABSTRACTThe approval of disease-modifying treatment in spinal muscular atrophy made the condition less severe. The course of the disease changed, but some new concerns occurred with the different new therapies. The side effects of onasemnogene aboparvovec therapy can raise differential diagnostic challenges and necessitate immune therapy, leading to immunosuppression affecting response to vaccines. We provide a pretherapy screening proposal from an infectological point of view separately for newborns treated presymptomaticall...
Source: European Journal of Paediatric Neurology - March 8, 2024 Category: Neurology Authors: Sarolta Dobner Andrea Kulcs ár Zolt án Liptai Zsuzsanna Vojnisek Tam ás Constantin L éna Szabó Source Type: research

Vaccination proposal for patients on onasemnogene abeparvovec therapy
Eur J Paediatr Neurol. 2024 Mar 1;49:95-99. doi: 10.1016/j.ejpn.2024.02.010. Online ahead of print.ABSTRACTThe approval of disease-modifying treatment in spinal muscular atrophy made the condition less severe. The course of the disease changed, but some new concerns occurred with the different new therapies. The side effects of onasemnogene aboparvovec therapy can raise differential diagnostic challenges and necessitate immune therapy, leading to immunosuppression affecting response to vaccines. We provide a pretherapy screening proposal from an infectological point of view separately for newborns treated presymptomaticall...
Source: European Journal of Paediatric Neurology - March 8, 2024 Category: Neurology Authors: Sarolta Dobner Andrea Kulcs ár Zolt án Liptai Zsuzsanna Vojnisek Tam ás Constantin L éna Szabó Source Type: research

Be aware of childhood stroke: Proceedings from EPNS Webinar
In conclusion, childhood AIS is a growing concern. Understanding the increasing incidence, age distribution, risk factors, clinical presentation, diagnostic approach, and management strategies is crucial for optimized management of these patients.PMID:38447504 | DOI:10.1016/j.ejpn.2024.02.001 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 6, 2024 Category: Neurology Authors: Gabriela Oesch Robin M ünger Maja Steinlin Source Type: research

Be aware of childhood stroke: Proceedings from EPNS Webinar
In conclusion, childhood AIS is a growing concern. Understanding the increasing incidence, age distribution, risk factors, clinical presentation, diagnostic approach, and management strategies is crucial for optimized management of these patients.PMID:38447504 | DOI:10.1016/j.ejpn.2024.02.001 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 6, 2024 Category: Neurology Authors: Gabriela Oesch Robin M ünger Maja Steinlin Source Type: research

Editorial commentary on "myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital"
Eur J Paediatr Neurol. 2024 Feb 19:S1090-3798(24)00016-3. doi: 10.1016/j.ejpn.2024.02.009. Online ahead of print.NO ABSTRACTPMID:38443292 | DOI:10.1016/j.ejpn.2024.02.009 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 5, 2024 Category: Neurology Authors: Thomas Sejersen Source Type: research

Editorial commentary on "myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital"
Eur J Paediatr Neurol. 2024 Feb 19:S1090-3798(24)00016-3. doi: 10.1016/j.ejpn.2024.02.009. Online ahead of print.NO ABSTRACTPMID:38443292 | DOI:10.1016/j.ejpn.2024.02.009 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 5, 2024 Category: Neurology Authors: Thomas Sejersen Source Type: research

Unmet health care needs over the first 2 years after pediatric traumatic brain injury
CONCLUSION: Pediatric patients with TBI may have long-term symptom burden affecting school and social functioning, leading to unmet needs if targeted services are not provided.PMID:38430714 | DOI:10.1016/j.ejpn.2024.01.002 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 2, 2024 Category: Neurology Authors: Hilde Margrete Dahl Ingvil Laberg Holthe Nada Andelic Marianne L øvstad Mia C Myhre Source Type: research

The promise of personalized medicine in pediatric epilepsy - The time has come
Eur J Paediatr Neurol. 2024 Feb 20:S1090-3798(24)00018-7. doi: 10.1016/j.ejpn.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38431515 | DOI:10.1016/j.ejpn.2024.02.011 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 2, 2024 Category: Neurology Authors: Phillip L Pearl Source Type: research

Unmet health care needs over the first 2 years after pediatric traumatic brain injury
CONCLUSION: Pediatric patients with TBI may have long-term symptom burden affecting school and social functioning, leading to unmet needs if targeted services are not provided.PMID:38430714 | DOI:10.1016/j.ejpn.2024.01.002 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 2, 2024 Category: Neurology Authors: Hilde Margrete Dahl Ingvil Laberg Holthe Nada Andelic Marianne L øvstad Mia C Myhre Source Type: research

The promise of personalized medicine in pediatric epilepsy - The time has come
Eur J Paediatr Neurol. 2024 Feb 20:S1090-3798(24)00018-7. doi: 10.1016/j.ejpn.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38431515 | DOI:10.1016/j.ejpn.2024.02.011 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 2, 2024 Category: Neurology Authors: Phillip L Pearl Source Type: research

Unmet health care needs over the first 2 years after pediatric traumatic brain injury
CONCLUSION: Pediatric patients with TBI may have long-term symptom burden affecting school and social functioning, leading to unmet needs if targeted services are not provided.PMID:38430714 | DOI:10.1016/j.ejpn.2024.01.002 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 2, 2024 Category: Neurology Authors: Hilde Margrete Dahl Ingvil Laberg Holthe Nada Andelic Marianne L øvstad Mia C Myhre Source Type: research

The promise of personalized medicine in pediatric epilepsy - The time has come
Eur J Paediatr Neurol. 2024 Feb 20:S1090-3798(24)00018-7. doi: 10.1016/j.ejpn.2024.02.011. Online ahead of print.NO ABSTRACTPMID:38431515 | DOI:10.1016/j.ejpn.2024.02.011 (Source: European Journal of Paediatric Neurology)
Source: European Journal of Paediatric Neurology - March 2, 2024 Category: Neurology Authors: Phillip L Pearl Source Type: research